Moderna finalized an agreement with Kenya’s government on Monday to build the U.S.-based pharmaceutical giant’s first manufacturing facility for mRNA vaccines on the African continent, Africanews reported Tuesday.
Moderna Inks $500 Million Deal with Kenya for mRNA Vaccine Facility
